Literature DB >> 17229917

Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree.

Guy Decaux1, Frédéric Vandergheynst, Yasmina Bouko, Jasmine Parma, Gilbert Vassart, Catheline Vilain.   

Abstract

Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is a recently described genetic cause of hyponatremia in male infants. Whether this X-linked condition could be detected in the adult or also could affect women is unknown. A large five-generation family was identified in which the recently described arginine-vasopressin receptor type 2 (AVPR2) mutation that is responsible for NSIAD was segregated. The proband was a 74-yr-old patient who had a syndrome of inappropriate antidiuresis and whose hyponatremia resisted administration of two AVPR2 antagonists. The phenotype of family members who carry the mutation was investigated. Patients with normal serum sodium were subjected to a water-load test. The previously reported activating missense R137C mutation in the AVPR2 gene in three hemizygous male and four heterozygous female individuals was identified. Except in one woman, spontaneous episodes of hyponatremia or abnormal water-load test were identified in all patients with the mutation, whether male or female. Skewed X inactivation was evidenced in the blood of the asymptomatic woman, which is compatible with preferential inactivation of her mutated allele. NSIAD is not limited to male infants. The diagnosis also should be considered in both male and female adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229917     DOI: 10.1681/ASN.2006090987

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  43 in total

1.  [Language of the other].

Authors:  L von Ferber
Journal:  Fortschr Med       Date:  1975-12-04

2.  Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

Authors:  Beth Wilmot; V Saroja Voruganti; Yen-Pei C Chang; Yi Fu; Zhan Chen; Herman A Taylor; James G Wilson; Teresa Gipson; Vallabh O Shah; Jason G Umans; Michael F Flessner; Robert Hitzemann; Alan R Shuldiner; Anthony G Comuzzie; Shannon McWeeney; Philip G Zager; Jean W Maccluer; Shelley A Cole; David M Cohen
Journal:  Physiol Genomics       Date:  2011-12-20       Impact factor: 3.107

3.  American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 8.237

Review 4.  Vaptans for the treatment of hyponatremia.

Authors:  Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-02-01       Impact factor: 43.330

Review 5.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

6.  The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation.

Authors:  Julie Tenenbaum; Mohammed A Ayoub; Sanja Perkovska; Anne-Laure Adra-Delenne; Christiane Mendre; Bruno Ranchin; Giamperro Bricca; Ghislaine Geelen; Bernard Mouillac; Thierry Durroux; Denis Morin
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

7.  Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.

Authors:  Olivier Devuyst; Arlene B Chapman; Ron T Gansevoort; Eiji Higashihara; Ronald D Perrone; Vicente E Torres; Jaime D Blais; Wen Zhou; John Ouyang; Frank S Czerwiec
Journal:  J Am Soc Nephrol       Date:  2016-12-05       Impact factor: 10.121

8.  Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Martina Kocan; Heng B See; Natália G Sampaio; Karin A Eidne; Brian J Feldman; Kevin D G Pfleger
Journal:  Mol Endocrinol       Date:  2009-01-29

Review 9.  Focus on neonatal and infantile onset of nephrogenic syndrome of inappropriate antidiuresis: 12 years later.

Authors:  Flaminia Bardanzellu; Maria Cristina Pintus; Valentina Masile; Vassilios Fanos; Maria Antonietta Marcialis
Journal:  Pediatr Nephrol       Date:  2018-03-15       Impact factor: 3.714

10.  Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Yoon Hi Cho; Stephen Gitelman; Stephen Rosenthal; Geoffrey Ambler
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.